Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Clinical Model Identifies H1N1 Influenza-Related Pneumonia

By HospiMedica International staff writers
Posted on 24 Mar 2011
A diagnostic model based on five clinical criteria effectively distinguishes H1N1 influenza-related pneumonia from inter-pandemic community-acquired pneumonia (CAP), reports a new study.

Researchers at Nottingham University Hospitals NHS Trust (United Kingdom) studied data collected by the UK Influenza Clinical Information Network (FLU-CIN) on 1,046 adults admitted to 75 hospitals with confirmed H1N1 influenza, between May 2009 and January 2010. More...
Of these, 254 were found to have H1N1 influenza-related pneumonia on admission. Clinical and epidemiological information from these 254 patients were compared with that from 648 adults with CAP who were admitted to hospital between September 2008 and June 2010, excluding those admitted during the period of the pandemic.

The results of the study showed that although both groups had similar levels of in-hospital mortality (11.4% for the H1N1 cohort, compared to 14.0% in the CAP cohort), they differed significantly on a number of clinical characteristics. Analysis revealed five clinical criteria that distinguished between the cohorts; these included age younger than 65 years, bilateral radiographic change, mental orientation (i.e., awareness of time, place, and person), a low leucocyte count, and body temperature of over 38 °C. By assigning a score of one point for each of these five clinical criteria, the team found that a score of 4 or 5 gave a positive likelihood ratio of 9.0 for predicting H1N1 influenza-related pneumonia, while a score of 0 or 1 gave a positive likelihood ratio of 75.7 for excluding it. The study was published in the March 2011 issue of Thorax.

"A model based on five simple clinical criteria… allows the early discrimination of H1N1 influenza-related pneumonia from CAP following hospital admission and confers confidence to the instigation of early empirical antiviral therapy,” concluded lead author consultant respiratory physician Wei Shen Lim, MD, and colleagues of the department of respiratory medicine.

Related Links:
Nottingham University Hospitals NHS Trust




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.